Quote this publication Share Print

ADENURIC

-
Opinions on drugs - Posted on Jun 04 2012

Reason for request

Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.

-


Clinical Benefit

Substantial

The actual benefit of ADENUIRC is substantial.


Clinical Added Value

minor

The Transparency Committee considers that ADENURIC provides a minor improvement in actual benefit (level IV) in the management of symptomatic chronic hyperuricaemia compared to the current therapeutic strategy based on allopurinol.


Contact Us

Évaluation des médicaments

See also